Circulation

JUNE 4, 2024

The human capital approach was used to estimate productivity losses from morbidity and premature mortality due to cardiovascular conditions.RESULTS:One in 3 US adults received care for a cardiovascular risk factor or condition in 2020. Circulation, Ahead of Print.

Cardiovascular Disease 75

Cardiovascular Disease Risk Factors Stroke Strokes 75

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Meanwhile, the risk of suffering from cardiovascular disease (CVD) has been increasing with ageing. Cancer, atrial fibrillation (AF) and coronary artery disease share some common factors and interact with each other, such as obesity, aging, diabetes, and inflammation, but the potential specific mechanism is still unclear.

Atrial Fibrillation 64

Atrial Fibrillation Cancer Embolism Coronary Artery Disease 64

Heart BMJ

APRIL 25, 2024

Atrial fibrillation (AF) is the most common sustained cardiac rhythm disorder, affecting an estimated 43 million people globally. Atrial fibrillation (AF) is the most common sustained cardiac rhythm disorder, affecting an estimated 43 million people globally.

Atrial Fibrillation 52

Atrial Fibrillation Public Health Outpatient Heart Failure 52

DAIC

JANUARY 5, 2024

Medtronic Creates History with FDA Approval of its Novel PulseSelect Pulsed Field Ablation System to Treat Atrial Fibrillation 3. FDA Approves First Anti-Inflammatory Drug for Cardiovascular Disease 4. AHA and ACC Issue New Clinical Guideline for Chronic Coronary Disease 5.

Atrial Fibrillation 105

Atrial Fibrillation Aortic valve Cardiothoracic Interventional Cardiology 105

Frontiers in Cardiovascular Medicine

APRIL 16, 2024

Atrial fibrillation (AF) is the most common heart rhythm disorder in clinical practice. The current pandemic of a new coronavirus infection, which began in March 2020, was marked by an increase in cardiovascular diseases, including an increase in the number of patients with AF.

COVID-19 52

COVID-19 Atrial Fibrillation Quality of Life Outpatient 52

Open Heart

MARCH 19, 2024

There is an escalating trend in both the incidence and prevalence of atrial fibrillation (AF). AF is linked to numerous other comorbidities, contributing to the emergence of multimorbidity. The sustained rise in multimorbidity and AF prevalences exerts a significant strain on healthcare systems globally.

Atrial Fibrillation 52

Atrial Fibrillation Cardiovascular Disease Outcomes 52

Frontiers in Cardiovascular Medicine

FEBRUARY 14, 2024

Background Observational studies have indicated a potential association between education and cardiovascular diseases (CVDs). However, uncertainties regarding the causal relationship persist. Therefore, this study aimed to investigate whether higher levels of education causally reduce the risks of CVDs.

Education 49

Education Cardiovascular Disease Peripheral Arterial Disease Genetic predisposition 49

HeartRhythm

APRIL 30, 2024

Glucagon-like peptide-1 agonists (GLP-1) have been a breakthrough medication for the treatment of patients with cardiovascular disease. Studies have suggested that GLP-1 may reduce atrial fibrosis and atrial fibrillation (AF) recurrence following catheter ablation.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Cardiovascular Disease Outcomes 40

HeartRhythm

AUGUST 23, 2023

Atrial fibrillation (AF) has been accepted as an inflammatory atrial myopathy. Interleukin 6 (IL-6)–dependent inflammatory signaling pathways take context-dependent effects on cardiovascular diseases. IL-6 trans-signaling is predominantly pro-inflammatory. However, its effect on AF is unclear.

Atrial Fibrillation 40

Atrial Fibrillation Cardiovascular Disease 40

DAIC

FEBRUARY 27, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , announced the commencement of patient cases with the investigational Laminar Left Atrial Appendage Elimination (LAAX) System as part of its pivotal investigational device exemption (IDE) study.

Atrial Fibrillation 105

Atrial Fibrillation Innovation AFIB Pharmacology 105

HeartRhythm

JANUARY 23, 2025

The prevalence of atrial fibrillation (AF) in patients with type 2 diabetes mellitus (T2DM) is reported to be higher than in the general population, ranging from 3.6% to 8.9 % [1].

Atrial Fibrillation 40

Atrial Fibrillation Diabetes Outcomes Cardiovascular Disease 40

Open Heart

DECEMBER 14, 2023

Objective Cardiovascular multimorbidity (CVM) is the co-occurrence of multiple cardiovascular disease subtypes (CVDs) in one person. The pair of CVDs with the highest age-adjusted incidence was ischaemic heart disease and atrial fibrillation (18.95 per 10 000 person-years).

Cardiovascular Disease 52

Cardiovascular Disease Atrial Fibrillation Public Health Heart Disease 52

American College of Cardiology

JANUARY 8, 2024

Obesity is a multifaceted disease that is directly and indirectly implicated in atherosclerotic cardiovascular disease (CVD), heart failure (HF), atrial fibrillation (AF), and multiple CVD risk factors, including dyslipidemia, hypertension, type 2 diabetes mellitus (DM), and sleep disorders.

Obesity 70

Obesity Atrial Fibrillation Heart Failure Risk Factors 70

HeartRhythm

APRIL 30, 2024

Leukocyte telomere length (LTL) is a well-established biomarker linked to cardiovascular disease, with shorter LTL associated with increased severity of heart failure (HF) outcomes. It is also well known that atrial fibrillation (AF) and HF are closely related and often coexist.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Biomarkers Cardiovascular Disease 40

HeartRhythm

NOVEMBER 5, 2024

Atrial fibrillation (AF) is the most common arrhythmia in the U.S., Black Americans are less prone to develop AF than White Americans, but they display a higher burden of modifiable risk factors for cardiovascular disease and higher rates of ischemic stroke.

Atrial Fibrillation 40

Atrial Fibrillation Risk Factors Genetic predisposition Cardiovascular Disease 40

Journal of the American Heart Association

DECEMBER 29, 2023

BackgroundDespite the health effects of basal metabolic rate (BMR), the causal effect of BMR on cardiovascular diseases (CVDs) remains undetermined. 1.67];P<0.001), atrial fibrillation and flutter (odds ratio, 2.12 [95% CI, 1.87–2.40];P<0.001), Journal of the American Heart Association, Ahead of Print.

Cardiovascular Disease 45

Cardiovascular Disease Atrial Fibrillation Aneurysm Coronary Artery Disease 45

DAIC

JUNE 18, 2024

A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 population could be affected by cardiovascular disease within the next 30 years, according to two new science reports. to 61% of the U.S. population.

Heart Disease 105

Heart Disease Blood Pressure Stroke Strokes 105

HeartRhythm

APRIL 30, 2024

Lower (worse) left atrial (LA) function—a hallmark of atrial myopathy—is linked to higher risk of ischemic stroke independent of atrial fibrillation (AF).

Atrial Fibrillation 40

Atrial Fibrillation Stroke Strokes Cardiovascular Disease 40

All About Cardiovascular System and Disorders

FEBRUARY 27, 2024

There are several factors which increase the risk of cardiovascular disease in survivors of spinal cord injury. Higher risk of myocardial infarction, heart failure and atrial fibrillation was noted in spinal cord injury survivors compared to controls. Survivors with severe disability had the highest risk. PMID: 17251696.

Myocardial Infarction 40

Myocardial Infarction Atrial Fibrillation Heart Failure Blood Pressure 40

Frontiers in Cardiovascular Medicine

JANUARY 9, 2024

Background and aims It is uncertain if there is a link between non-alcoholic fatty liver disease (NAFLD) and cardiovascular diseases (CVD) in young adults and children. Further subgroup analyses showed that individuals with NAFLD were at a heightened risk of coronary heart disease (CHD) (HR = 3.10, 95% CI: 2.01–4.77,

Cardiovascular Disease 59

Cardiovascular Disease Myocardial Infarction Atrial Fibrillation Heart Failure 59

American College of Cardiology

JULY 2, 2024

In this week’s View, Dr. Eagle looks at the clinical impact of early rhythm control and healthy lifestyles in patients with atrial fibrillation, then explores the use of low-dose aspirin in the prevention of atherosclerotic cardiovascular disease.

Atherosclerosis 52

Atherosclerosis Atrial Fibrillation Cardiovascular Disease Article 52

HeartRhythm

FEBRUARY 26, 2024

Back in the early 1990s, it was generally believed that the transition from paroxysmal to permanent AF was due to aging and/or the effect of an underlying cardiovascular disease such as hypertension, valvular defects, or heart failure.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Cardiovascular Disease Hypertension 40

Circulation

FEBRUARY 15, 2024

BACKGROUND:Clonal hematopoiesis of indeterminate potential (CHIP), a common age-associated phenomenon, associates with increased risk of both hematological malignancy and cardiovascular disease.

Atrial Fibrillation 45

Atrial Fibrillation Diet Myocardial Infarction Cardiovascular Disease 45

Circulation

NOVEMBER 11, 2024

Owing to improved management, the life expectancy of patients with hemophilia has increased significantly and predisposes them to risk of cardiovascular diseases and thrombotic events. The hemophilia cohort was slightly older (63.2[16.8]

Risk Factors 40

Risk Factors Cardiovascular Disease Coronary Artery Bypass Graft Outcomes 40

HeartRhythm

MAY 8, 2024

Previous research suggests that LLMs can provide accurate recommendations in the field of cardiovascular disease prevention. Large language models (LLM) are deep learning algorithms capable of performing natural language processing tasks, with open-access LLMs increasing used by the general public.1

Atrial Fibrillation 45

Atrial Fibrillation Cardiovascular Disease Research 45

Circulation

NOVEMBER 11, 2024

Background:Cancer and obstructive sleep apnea (OSA) individually elevate cardiovascular diseases (CVD) and stroke risk. Adverse CVD outcomes was defined as a composite of incident heart failure, incident atrial fibrillation / flutter, incident myocardial infarction or all-cause mortality.

Cancer 40

Cancer Cardiovascular Disease Myocardial Infarction Atrial Fibrillation 40

HeartRhythm

AUGUST 31, 2024

Patients with adrenal insufficiency (AI) have both increased risk of cardiovascular disease and adverse outcomes with many medical emergencies. However, limited data exist regarding Atrial Fibrillation in the context of AI.

Atrial Fibrillation 40

Atrial Fibrillation Outcomes Cardiovascular Disease 40

HeartRhythm

FEBRUARY 22, 2024

Frequent premature ventricular contractions (PVCs) and nonsustained ventricular tachycardia (NSVT) have been associated with cardiovascular disease and mortality. Their prevalence, especially in ambulatory populations, is under-studied and limited by few female participants and the use of short-duration (24-48 hour) monitoring.

Tachycardia 45

Tachycardia Atrial Fibrillation Cardiovascular Disease 45

DAIC

JULY 31, 2024

In its announcement about the workbook, ACC noted that cardiologists use digital devices and wearable technology to remotely monitor their patients for a variety of chronic cardiovascular diseases, including heart failure, coronary artery disease, vascular disease and atrial fibrillation.

Reimbursement 98

Reimbursement Technology Coronary Artery Disease Best Practices 98

DAIC

JANUARY 2, 2024

Medtronic Creates History with FDA Approval of its Novel PulseSelect Pulsed Field Ablation System to Treat Atrial Fibrillation 2. New Study Reveals Latest Data on Global Burden of Cardiovascular Disease 4. New Artificial Intelligence Tool Predicts Mortality After Heart Surgeries 3.

COVID-19 52

COVID-19 Atrial Fibrillation Ablation Interventional Cardiology 52

American College of Cardiology

FEBRUARY 21, 2024

In this week’s View, Dr. Eagle covers opportunities in the postpartum period to reduce cardiovascular disease risk after adverse pregnancy outcomes. He then explores the apparent increased risk of myocardial infarction, heart failure and atrial fibrillation after spinal cord injury.

Myocardial Infarction 40

Myocardial Infarction Atrial Fibrillation Heart Failure Cardiovascular Disease 40

DAIC

FEBRUARY 29, 2024

24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

HeartRhythm

SEPTEMBER 8, 2023

Atrial fibrillation (AF) stands as the most prevalent cardiovascular disease, posing significant risks of stroke, heart failure (HF), and other complications that contribute to morbidity and mortality.

Atrial Fibrillation 40

Atrial Fibrillation Electrophysiology Heart Failure Cardiovascular Disease 40

Journal of the American Heart Association

MARCH 27, 2025

Six multimorbidity patterns were identified, including 4 specific patterns: (1) pattern 1, cerebrovascular cluster (histories of cerebrovascular disease and hypertension); (2) pattern 2, traditional cardiovascular disease risk factors cluster (histories of hyperlipidemia, obesity, anddiabetes, and family history of cardiovascular disease and smoking); (..)

Myocardial Infarction 40

Myocardial Infarction Peripheral Arterial Disease Outcomes Chest Pain 40

Circulation

MARCH 11, 2024

Hematopoietic stem cell transplantation can cure various disorders but poses cardiovascular risks, especially for elderly patients and those with cardiovascular diseases. Cardiovascular evaluations are crucial in pretransplantation assessments, but guidelines are lacking. Circulation, Ahead of Print.

Transplant 45

Transplant Cardiovascular Disease Atrial Fibrillation Pediatrics 45

Journal of the American Heart Association

FEBRUARY 29, 2024

BackgroundThe ECG is a simple, noninvasive screening method for cardiovascular disease and arrhythmia. All‐cause mortality was associated with right atrial enlargement (HR, 2.11 [95% CI, 1.1–4.07]), 4.07]), left atrial enlargement (HR, 1.76 [95% CI, 1.1–2.84]), 4.2]), atrial fibrillation (HR, 1.52 [95% CI, 1.26–1.84]),

Atrial Fibrillation 40

Atrial Fibrillation Tachycardia Cardiovascular Disease Arrhythmia 40

The British Journal of Cardiology

NOVEMBER 29, 2023

The key risk factor for cardioembolic stroke is atrial fibrillation or flutter, and oral anticoagulation (OAC) is recommended in all but the lowest-risk patients with evidence of these arrhythmias. Risk factors for thrombotic stroke overlap strongly with those for other atherosclerotic cardiovascular diseases (ASCVDs).

Stroke 40

Stroke Strokes Risk Factors Blood Pressure 40